PharmaCyte Biotech Inc (PMCB)

[PersianMeow]

Twin studies are usually a great indicator of the predisposition someone will have to a particular ailment.

After I read your comment I had to go fulfill my inner "need to know"


RESULTS—The disease-associated INS genotype (Hph I) was identified in 87.5% of the concordant twins but only in 59.5% (P = 0.005) of the discordant twins. Neither DQB1*0201 nor DQB1*0302 was seen in 2 of 40 (5%) concordant twins compared with 8 of 37 (22%) discordant twins (P = 0.04). No statistical differences were seen between concordant and discordant twins at individual alleles of DQB1. Combining insulin and DQ data, 5% of concordant twins compared with 32.4% of discordant twins had neither DQB1*0201/DQB1*0302 nor the high-risk Hph I INS “++” genotype (P = 0.002).

CONCLUSIONS—We conclude that the possession of the high-risk Hph I insulin genotype increases the likelihood of identical twins being concordant for type 1 diabetes and that the “load” of both major histocompatibility complex (MHC) and non-MHC susceptibility genes has an impact on the disease penetrance of type 1 diabetes.

http://care.diabetesjournals.org/content/24/5/838

Anyways, the type ones that technology you two are talking about sounds promising. Research is also shedding light on what an intricate role our microbiota plays in our health.

Hope you all are having a good day and thank you for the info on the conferences.